title: [Still's disease in adults: treatment with intravenous immunoglobulins].
abstract: BACKGROUND
  Adult onset Still's disease is a rare systemic disorder of unknown etiology occurring in young adults. The diagnosis is based upon Yamaguchi criteria. Treatment is difficult and not well codified.
  
  
  BACKGROUND
  Non steroidal anti-inflammatory drugs (salicylates, indomethacin) are used as first-line therapy but are not efficient. Steroids are needed in 80% of cases to control systemic manifestations of adult onset Still's disease. Immunosuppressive agents, such as methotrexate, are necessary when a high dose of steroids are required. The use of intravenous immunoglobulin was rarely reported, in particular in patients refractory to non steroidal anti-inflammatory drugs. Intravenous immunoglobulin was administered at 2 g/kg of body weight during two or five days. Infusion was given monthly for four-six cycles. Long-term remission was obtained in half of the patients. Precise mechanisms of action of intravenous immunoglobulin in adult onset Still's disease remain unclear.
  
  
  CONCLUSIONS
  Intravenous immunoglobulin may represent a new treatment, particularly in patients refractory to non steroidal anti-inflammatory drugs before the use of steroids. Further prospective works are needed to confirm these preliminary optimistic data.
authors.affiliation: Service de médecine interne, Hôpital de la Pitié-Salpêtrière, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Vignes
authors.forename: B
authors.initials: B
authors.lastname: Wechsler
mesh_terms: D000328:Adult; D017668:Age of Onset; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001835:Body Weight; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use*; D007388:Internal Medicine / Q000379:methods; D012074:Remission Induction / Q000379:methods; D013256:Steroids; D016706:Still's Disease, Adult-Onset / Q000145:classification / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous; D013256:Steroids